Diagnostic Contribution of Endobronchial Optical Coherence Tomography in the Multidisciplinary Diagnosis of Interstitial Lung Disease.
Arao RK; Yamamoto S; Nandy S; Sharma A; Lee J; Berigei SR
Abstract
BACKGROUND: Less-invasive, lower-risk alternatives to surgical lung biopsy (SLB) have emerged for interstitial lung disease (ILD) diagnosis, such as transbronchial lung cryobiopsy (TBLC) and Envisia Genomic Classifier (EGC), but suffer from limited sampling and simplified binomial classification, respectively. Endobronchial optical coherence tomography (EB-OCT) is a low-risk, large-volume bronchoscopic imaging modality with microscopic resolution, which accurately detects features and patterns for ILD diagnosis as previously validated against SLB. RESEARCH QUESTION: How does EB-OCT contribute to ILD diagnosis and diagnostic confidence at multidisciplinary discussion (MDD) when paired with clinically indicated TBLC and EGC? STUDY DESIGN AND METHODS: Patients with low-confidence ILD diagnosis clinically referred for both TBLC with EGC were enrolled to undergo concurrent EB-OCT imaging. Each modality was interpreted independently by blinded pathologists. Separate MDD sessions were conducted at two independent sites, including one without prior EB-OCT experience. RESULTS: Fifteen patients were included (9 male; mean age: 70.6 years) with final diagnoses of UIP/IPF (n=5), secondary UIP (n=2), and various non-UIP ILDs (n=8) in agreement at both MDDs. EB-OCT provided diagnostic data that was in agreement with final MDD diagnosis for 100% of subjects (15/15), including in the 40% of subjects (6/15) where TBLC was non-diagnostic. In the subjects where TBLC yielded diagnostic data (60%, 9/15), EB-OCT diagnosis was in agreement. EB-OCT combined with TBLC/EGC increased diagnostic confidence and/or narrowed the differential diagnosis from baseline clinical/radiologic data review in all subjects, with replication across both independent MDDs. INTERPRETATION: In this pilot study, we demonstrate EB-OCT is a safe, large-volume imaging method that detects microscopic features and patterns for ILD diagnosis, which increases diagnostic confidence in the context of MDD and complements TBLC and EGC. Future multicenter studies are needed to further validate these findings.
This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
Clinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
Up nextJournal of Thoracic DiseaseOct 30, 2026Read
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.